Condition
Lower Extremity Wound
Total Trials
6
Recruiting
2
Active
2
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 4 (1)
Trial Status
Completed3
Recruiting2
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05243966Recruiting
Myriad™ Augmented Soft Tissue Reconstruction Registry
NCT05739149Not ApplicableRecruiting
A Study to Evaluate Microvessel Ultrasound Imaging of Wound Healing in Patients With Chronic Ulcers
NCT05087758Not ApplicableCompleted
Matrion™ Decellularized Placental Membrane in Subjects With Diabetic Foot Ulcers
NCT05426161Phase 4Completed
The Effect of Subcutaneous Injection of Botulinum Toxin A on Chronic Wound Pain in Lower Extremities
NCT04826965Not ApplicableTerminated
VAC Bioburden Wound Care Assessment
NCT03044132Not ApplicableCompleted
DermACELL AWM® in Chronic Wagner Grade 3/4 Diabetic Foot Ulcers
Showing all 6 trials